Alliance for Pandemic Preparedness

March 16, 2020

Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan

Category:

Topic:

  • In this case report, the authors describe the clinical course and management of 3 cases from a family in Wuhan and suggest expected therapeutic effects of a Chinese traditional patent medicine, Shuanghuanglian oral liquid on COVID-19, and warrant further clinical trials.
  • In another study of 2 mild and 2 severe COVID-19 pneumonia patients who were given combined Chinese and Western medicine treatment, 3 of them showed significant improvements in pneumonia associated symptoms. Efficacy of the traditional Chinese medicine (SFJDC -Shufeng Jiedu Capsule) needs further verification.

Ni et al. (Mar 13, 2020). Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan. Front. Med. https://doi.org/10.1007/s11684-020-0757-x 

Wang et al. (Feb 9, 2020). Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. BioScience Trends. https://doi.org/10.5582/bst.2020.01030